Prognostic importance of the psychopathological remission structure at the initial stage of schizophrenia

Barkhatova A.N.

doi:https://doi.org/10.17116/jnevro20191190315

Close metadata

Recommended articles:

The association of NOS1AP gene polymorphisms with the duration of the QT interval in patients with schizophrenia receiving antipsychotic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):98-104

PANSS six-factor model. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):28-34

Clinical and immunological relationships in patients with early schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):35-42

Clinical and psychopathological features of treatment-resistant schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):43-50

Analysis of cognitive status in patients with different nosologies and clinical variants of very late manifesting schizophreniform psychosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):88-93

Modern concepts of sleep disturbances associated with mental disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12

Factors influencing the achievement of remission in patients with alcohol dependence and concomitant psychological disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):21-30

Association of cortisol levels with psychopathological features of depression and therapeutic response in female patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):45-54

Factors supporting chronic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15

Quantitative electroencephalogram in females at different stages of alcohol remission. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):122-126

Abstract:

Objective. To identify main clinical and psychopathological models of remission in the initial stage of schizophrenia which were correlated with subsequent clinical and social prognosis. Material and methods. The sample consisted of 116 patients diagnosed with paroxysmal-progressive schizophrenia (ICD-10 items F20.01—F20.09) in remission after the first or second episode. Clinical-psychopathological, psychometric (SPI-A), statistical methods were used. The separation of remissions in the initial stage of schizophrenia was based on the principle of longitudinal observation with estimation of correlations between deficit disorders and positive symptoms. Results and conclusion. Depending on the predominance of one of the factors of the deficit symptom complex, the following modules were identified: remissions with domination of deficit expression factor and remissions with deficit apathy factor, which were correlated with the clinical and social prognosis.

Keywords:

schizophrenia

basic disorders

deficit disorders

remission

manifestation

prediction factors

social prognosis

Authors:

Barkhatova A.N.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Close metadata

References:

Bleicher VM, Kruk IV. The explanatory dictionary of psychiatric terms. Voronezh: NPO MODEK; 1995. (In Russ.)
Smulevich AB, Romanov AV, Voronova EI, Mukhorina AK, Chitlova VV, Sorokina OYu. 2009; 2017; Evolution of the doctrine of schizophrenic defect. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117:9:4-14. (In Russ.)
Tiganov AS. (Ed.) Psychiatry. Scientific and practical reference book. 2016. (In Russ.)
Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353-370. https://doi.org/10.1093/schbul/22.2.353
Malla AK, Norman AM, Manchanda R, Townsend L. Symptoms, cognition, treatment and functional outcome in first episode psychosis. Psychol Med. 2002;32:6:1109-1119.
Wolter A, Preuss VW, Krischke NR. Remission, prediction and stability of symptoms in schizophrenia: a naturalistic 12-month follow-up study. Inter J Psychiat Clin Pract. 2010;14:160-167. https://doi.org/10.3109/13651500903531365
Valencia M, Fresán A, Barak Y, Juárez F, Escamilla R, Saracco R. Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome. Neuropsychiatr Dis Treat. 2015;11:2339-2348. https://doi.org/10.2147/NDT.S87335
Emsley R, Chiliza B, Asmal L, Lehloenya K. The concepts of remission and recovery in schizophrenia. Curr Opin Psychiatry. 2011;24:114-121. https://doi.org/10.1097/YCO.0b013e3283436ea3
van Os J, Burns T, Cavallaro R, Leucht S, Peuskens J, Helldin L, Bernardo M, Arango C, Fleischhacker W, Lachaux B, Kane JM. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand. 2006;113(2):91-95. https://doi.org/10.1111/j.1600-0447.2005.00659.x
Gorwood P, Peuskens J. European Group On Functional Outcomes, Remission in Schizophrenia. Setting new standards in schizophrenia outcomes: symptomatic remission 3 years before versus after the Andreasen criteria. Eur Psychiatry. 2012;27(3):170-175. Epub 2011 Jun 8. https://doi.org/10.1016/j.eurpsy.2010.12.011
Lahera G, Gálvez JL, Sánchez P, Martínez-Roig M, Pérez-Fuster JV, García-Portilla P, Herrera B, Roca M. Functional recovery in patients with schizophrenia: recommendations from a panel of experts. BMC Psychiatry. 2018;18(1):176. https://doi.org/10.1186/s12888-018-1755-2
Zhang T, Xu L, Tang Y, Li H, Tang X, Cui H, Wei Y, Wang Y, Hu Q, Liu X, Li C, Lu Z, McCarley RW, Seidman LJ, Wang J. SHARP (ShangHai At Risk for Psychosis) Study Group Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator. Psychol Med. 2018;1-9. https://doi.org/10.1017/S0033291718002738
Norman RM, Malla AK. Prodromal symptoms of relapse in schizophrenia: a review. Schizophr Bull. 1995;21:527-539. https://doi.org/10.1093/schbul/21.4.527
Gaebel W, Riesbeck M. Revisiting the relapse predictive validity of prodromal symptoms in schizophrenia. Schizophr Res. 2007;95:19-29. https://doi.org/10.1016/j.schres.2007.06.016
Jansarik W. Dynamische Grundkonstellation in endogenen Psychosen. Berlin: Springer; 1959.
Carpenter W, Heinrichs D, Wagman A. Defizit and nondefizit forms of schizophrenia: The concept. Am J Psychiatry. 1988;145:5:578-583. https://doi.org/10.1176/ajp.145.5.578
Omelchenko MA, Rumyantsev AO, Kaleda VG. Dynamics of psychopathological symptoms of ultra-high risk of manifestation of schizophrenia in patients with non-psychotic mental disorders of adolescence Magazine. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2016;116(2):16-21. (In Russ.) https://doi.org/10.17116/jnevro20161162116-21
Fusar-Poli P, Bonoldi I, Yung A, Borgwardt S, Kempton M, Barale F, Caverzasi E, McGuire P. Prediction psychosis: meta-analysis of transition outcome in individuals at high clinical risk. Arch Gen Psychiatry. 2012;69(3):220-229. https://doi.org/10.1001/archgenpsychiatry.2011.1472
Omelchenko MA, Golubev SA, Nikiforova IYu, Kaleda VG. The risk of manifestation of endogenous psychosis in patients with non-psychotic mental disorders of adolescence. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2014;114:6:14-20. (In Russ.)
Kaleda VG, Mezentseva OE, Krylova ES, Barkhatova AN. Features domenifestnogo stage of endogenous psychosis with the first attack in adolescence. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2012;112(5):22-28. (In Russ.)
Snezhnevsky AV. Symptomatology and nosology. In the book: Schizofrenia. Clinic and pathogenesis. M. 1969. (In Russ.)
Addington D, Klosterkotter J, Ruhrman S, Schultz-Luther F. A tool for assessing susceptibility to schizophrenia (SPI-A). Adult version (SPI-A). Per. Skugarevskaya M., Alison A. ISBN E-book: 9788895930572. (In Russ.)
Marder SR, Galderisi S The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017;16(1):14-24. https://doi.org/10.1002/wps.20385
Kaiser S, Lyne J, Agartz I, Clarke M, Mørch-Johnsen L, Faerden A. Individual negative symptoms and domains — Relevance for assessment, pathomechanisms and treatment. Schizophr Res. 2017;186:39-45. Epub 2016 Jul 21. https://doi.org/10.1016/j.schres.2016.07.013
Kronfeld AS. Problems of syndromology and nosology in modern psychiatry. Preface Kutko I.I., Moskalenko V.F. Kharkov: Basis; 1996. (In Russ.)
Huber G. Reine Defektsyndrome und Basisstadien endogener Psychosen. Fortschr Neurol Psychiat. 1966;34:409-415.
Huber G. Das Konzept substratnaher Basissymptome und seine Bedeutung fur Theorie und Therapie schizophrener Erkrankungen. Nervenarzt. 1983;54:23-32.
Ebel H, Gross G, Klosterkötter J, Huber G. Basic symptoms in schizophrenic and affective psychoses. Psychopathology. 1989;22(4):224-232.
Skugarevsky OA, Skugarevskaya MM. Possibilities of early diagnosis and prevention of psychosis. Bulletin of psychiatry and psychology of Chuvashia. 2015;11:2:10-25. (In Russ.)
Huber G. Indizien für die Somatosehypothese bei den Schizophrenien Fortschr. Neurol Psychiat. 1976;44:77-94.
Ivanov MV, Neznanov NG. Negative and cognitive disorders in endogenous psychosis: diagnosis, clinic, therapy. SPb.: SPbNIPI them. V.M. Bekhtereva; 2008. (In Russ.)
Kotsyubinsky AP, Erichev AN, Klaiman VO, Shmonina OD. The biopsychosocial model of schizophrenia and early non-adaptive regimens. Part 1. Vulnerability—diathesis—stress. Review of Psychiatry and Medical Psychology. 2016;2:3-7. (In Russ.)
Cognition in schizophrenia. Impairments, importance, and treatment strategies. Ed. by Oxford: University Press; 2000. Sotsial'naya i klinicheskaya psikhiatriya. 2001;3:106-108. [Sharma T, Harvey Ph. Cognition in schizophrenia: disorders, their significance and therapeutic strategies. Short Translated from English. Ed. Sharma T., Harvey Ph. Cognition in schizophrenia. Impairments, importance, and treatment strategies. Ed. by Oxford: University Press; 2000. Social and Clinical Psychiatry. 2001;3:106-108. (In Russ.)
Smulevich AB. Personality disorders. Study guide. M.: Medical Information Agency; 2007. (In Russ.)
Cannon TD, van Erp TGM, Rosso IM, et al. Fetal Hypoxia and Structural Brain Abnormalities in Schizophrenic Patients, Their Siblings, and Controls. Arch Gen Psychiatry. 2002;59:35-41.
Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, Buchanan RW, Green MF, Carpenter WT Jr. Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res. 2013;47:783-790. https://doi.org/10.1016/j.jpsychires.2013.01.015
Faerden A, Barrett EA, Nesvagb R, Friisa S, Finsetd A, Mardere SR, Venturae J, Andreassena Ole A, Agartzb I, Melleaet I. Apathy, poor verbal memory and male gender predict lower psychosocial functioning one year after the first treatment of psychosis. Psychiatry Res. 2013;210(1):55-61. https://doi.org/10.1016/j.psychres.2013.02.007
Stephen R. Marder, Silvana Galderisi. The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 201716(1):14-24. https://doi.org/10.1002/wps.20385
Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker W, Kahn RS, Fleischhacker W, Boter H, Keet IPM, Brugman C, Davidson M, Dollfus S, Gaebel W, Gheorghe M, Gonen I, Grobbee DE, Hranov L, Hummer GM, Libiger J, Lindefors N, López-Ibor JJ, Nijssen K, Peuskens J, Prelipceanu D, Riecher-Rössler A, Rybakowski JK, Sedvall G, Von Wilmsdorff M. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. Eur Neuropsychopharmacol. 2013;23:196-204. https://doi.org/10.1016/j.euroneuro.2012.04.019